跳至主要内容
临床试验/NCT02876341
NCT02876341已完成不适用

Evaluating the Effect of Chronic Antihypertensive Therapy on New Onset Atrial Fibrillation and Clinical Outcomes in Septic Shock

Rush University Medical Center1 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
133
试验地点
1
主要终点
Cumulative percent (%) of patients with new onset atrial fibrillation at 48 hours

研究概览

简要总结

Retrospective two-cohort study to determine the effect of chronic antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic shock.

详细描述

This will be a retrospective two-cohort study to determine the effect of chronic antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic shock. The two cohorts will be septic shock patients that were: 1) not on either a chronic β-blocker or angiotensin-converting-enzyme inhibitor (ACE inhibitor) or 2) on a chronic β-blocker, on chronic ACE-Inhibitor, or on both chronic β-blocker and ACE-inhibitor

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients 18 years of age or older
  • Diagnosis of septic shock requiring vasopressor therapy (norepinephrine, epinephrine, phenylephrine, dopamine, or vasopressin)
  • Admitted to the medical intensive care unit (MICU) at Rush University Medical Center (RUMC)
  • Time frame: 01/01/2012 to 07/1/2016

排除标准

  • Pregnant patients
  • Transfer from outside hospital on vasopressors
  • Admitted to MICU in cardiopulmonary arrest
  • Prior arrest within 24 hours of admission to RUMC

结局指标

主要结局

Cumulative percent (%) of patients with new onset atrial fibrillation at 48 hours

时间窗: 48 hours

New onset atrial fibrillation defined as atrial fibrillation not present on admission to MICU

次要结局

  • Duration of mechanical ventilation(During admission)
  • In hospital mortality(During admission)
  • Heart rate > 100(48 hours)
  • New onset of other arrhythmias(48 hours)
  • Peak lactate(48 hours)
  • 28 day mortality(28 days after discharge)
  • New onset atrial fibrillation for patients on other antiarrhythmics(24 and 48 hours)
  • Cumulative percent (%) of patients with new onset atrial fibrillation at 24 hours(24 hours)
  • 90 day mortality(90 days after discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验